Is a complete ADAG research report available?

No complete published report is available for Adagene Inc. (ADAG) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Adagene Inc. (ADAG)

NASDAQ: ADAG · USD

$2.35

+0.06 (+2.6%)· Recorded snapshot

Market cap	157.8M
Revenue (ttm)	9.3M
Net income (ttm)	-20.5M
EPS (ttm)	-$0.39
Shares out	67.1M
Volume	107,351.354
Beta	0.66

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 9.3M
Net income (ttm): -20.5M
EPS (ttm): -$0.39
Market cap: 157.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	احتفاظ

Metric	Value
Amount currency	USD
CIK code	0001818838
Company name	Adagene Inc.
Country	China
Country code	US
CUSIP number	005329107
Earnings date	2026-08-12
Earnings time	bmo
Employees	128
Employees change	-10
Employees growth	-7.25%
Enterprise value	$36M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2011
Industry	Biotechnology
IPO date	2021-02-09
Is primary listing	Yes
Is SPAC	No
ISIN number	US0053291078
Last 10-K release date	2026-04-01
Last earnings date	2026-08-12
Last refreshed	2026-11-04
Last stock split type	Never
Market cap	$157.8M
Market cap category	Micro-Cap
Next earnings date	2027-03-31
Options	No
Price	$2.35
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-11-03
Symbol	ADAG
Website	https://www.adagene.com

Metric

Value

Amount currency

USD

CIK code

0001818838

Company name

Adagene Inc.

Country

China

Country code

CUSIP number

005329107

Earnings date

2026-08-12

Earnings time

bmo

Employees

128

Employees change

-10

Employees growth

-7.25%

Enterprise value

$36M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2011

Industry

Biotechnology

IPO date

2021-02-09

Is primary listing

Yes

Is SPAC

ISIN number

US0053291078

Last 10-K release date

2026-04-01

Last earnings date

2026-08-12

Last refreshed

2026-11-04

Last stock split type

Never

Market cap

$157.8M

Market cap category

Micro-Cap

Next earnings date

2027-03-31

Options

Price

$2.35

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-11-03

Symbol

ADAG

Website

https://www.adagene.com

Metric	Value
Earnings yield	-16.8%
EV/Sales	3.87x
FCF / EV yield	-53.99%
FCF yield	-12.31%
P/B ratio	1.76x
P/S ratio	16.98x
Price / tangible book value	1.76x
Sector forward P/E	23.32x
Sector P/E	49.47x

Metric

Value

Earnings yield

-16.8%

EV/Sales

3.87x

FCF / EV yield

-53.99%

FCF yield

-12.31%

P/B ratio

1.76x

P/S ratio

16.98x

Price / tangible book value

1.76x

Sector forward P/E

23.32x

Sector P/E

49.47x

Metric	Value
EBIT margin	-240.42%
EBITDA margin	-236.28%
Gross margin	100%
Operating margin	-240.42%
Pretax margin	-224.71%
Profit margin	-220.77%
Profit per employee	$-160,242
Revenue per employee	$72,584
ROA	-13.95%
ROA (5Y)	-22.54%
ROCE	-20.83%
ROE	-28.5%
ROE (5Y)	-49.41%
ROIC	-17.8%
SBC / revenue	41.36%
Tax / revenue	-3.94%

Metric

Value

EBIT margin

-240.42%

EBITDA margin

-236.28%

Gross margin

100%

Operating margin

-240.42%

Pretax margin

-224.71%

Profit margin

-220.77%

Profit per employee

$-160,242

Revenue per employee

$72,584

ROA

-13.95%

ROA (5Y)

-22.54%

ROCE

-20.83%

ROE

-28.5%

ROE (5Y)

-49.41%

ROIC

-17.8%

SBC / revenue

41.36%

Tax / revenue

-3.94%

Metric	Value
EPS growth years	1
Gross profit growth	8,902.38%
Gross profit growth 3Y	-25.72%
Gross profit growth 5Y	39.63%
Net income growth years	1
Revenue growth	8,902.38%
Revenue growth (QoQ)	-78.88%
Revenue growth 3Y	-25.72%
Revenue growth 5Y	39.63%
Revenue growth years	1

Metric

Value

EPS growth years

Gross profit growth

8,902.38%

Gross profit growth 3Y

-25.72%

Gross profit growth 5Y

39.63%

Net income growth years

Revenue growth

8,902.38%

Revenue growth (QoQ)

-78.88%

Revenue growth 3Y

-25.72%

Revenue growth 5Y

39.63%

Revenue growth years

Metric	Value
Capital expenditures	$-170,783
Depreciation and amortization	$384,223
EBIT	$-22.3M
EBITDA	$-22M
EPS	$-0.39
FCF per share	$-0.29
Financing cash flow	$83.9M
Free cash flow	$-19.4M
Free cash flow minus SBC	$-23.3M
Gross profit	$9.3M
Income taxes	$-366,334
Investing cash flow	$733,401
Net borrowing	$-1.2M
Net cash flow	$65.1M
Net income	$-20.5M
Operating cash flow minus SBC	$-23.1M
Operating income	$-22.3M
Revenue	$9.3M
Stock-based compensation	$3.8M

Metric

Value

Capital expenditures

$-170,783

Depreciation and amortization

$384,223

EBIT

$-22.3M

EBITDA

$-22M

EPS

$-0.39

FCF per share

$-0.29

Financing cash flow

$83.9M

Free cash flow

$-19.4M

Free cash flow minus SBC

$-23.3M

Gross profit

$9.3M

Income taxes

$-366,334

Investing cash flow

$733,401

Net borrowing

$-1.2M

Net cash flow

$65.1M

Net income

$-20.5M

Operating cash flow minus SBC

$-23.1M

Operating income

$-22.3M

Revenue

$9.3M

Stock-based compensation

$3.8M

Metric	Value
Altman Z-Score	-0.08
Book value per share	$1.33
Debt / equity	0.06
Interest coverage	-78.36
Long-term assets	$1.2M
Long-term liabilities	$1.2M
Net cash (debt)	$121.8M
Net cash / market cap	77.2%
Net cash growth	62.68%
Net debt / equity	-1.15
Piotroski F-Score	3
Property, plant and equipment	$1.1M
Shareholders' equity	$106M
Tangible book value	$89.5M
Tangible book value per share	$1.33
Total assets	$133.6M
Total cash	$127.9M
Total debt	$6.1M
Total liabilities	$27.6M
WACC	7.7%

Metric

Value

Altman Z-Score

-0.08

Book value per share

$1.33

Debt / equity

0.06

Interest coverage

-78.36

Long-term assets

$1.2M

Long-term liabilities

$1.2M

Net cash (debt)

$121.8M

Net cash / market cap

77.2%

Net cash growth

62.68%

Net debt / equity

-1.15

Piotroski F-Score

Property, plant and equipment

$1.1M

Shareholders' equity

$106M

Tangible book value

$89.5M

Tangible book value per share

$1.33

Total assets

$133.6M

Total cash

$127.9M

Total debt

$6.1M

Total liabilities

$27.6M

WACC

7.7%

Metric	Value
Asset turnover	0.09
Current assets	$132.4M
Current liabilities	$26.4M
Current ratio	5.02
Net working capital	$-17M
Quick ratio	4.86
Working capital	$106M
Working capital turnover	0.11

Metric

Value

Asset turnover

0.09

Current assets

$132.4M

Current liabilities

$26.4M

Current ratio

5.02

Net working capital

$-17M

Quick ratio

4.86

Working capital

$106M

Working capital turnover

0.11

Metric	Value
Buyback yield / dilution	-11.73%
Dividend yield	0%
Shareholder yield	-11.73%

Metric

Value

Buyback yield / dilution

-11.73%

Dividend yield

Shareholder yield

-11.73%

Metric	Value
150-day SMA	$3.52
1D price change	2.62%
1M price change	-17.54%
1M total return	-17.54%
1W price change	-8.91%
1W total return	-8.91%
1Y price change	32.02%
1Y return CAGR	32.05%
1Y total return	32.02%
20-day SMA	$2.50
200-day SMA	$3.43
3M price change	-37.33%
3M total return	-37.33%
3Y price change	73.82%
3Y return CAGR	20.24%
3Y total return	73.84%
50-day SMA	$2.99
50-day SMA vs 200-day SMA	50under200
52-week high	$4.85
52-week high date	2026-07-01
52-week low	$1.30
52-week low date	2025-11-07
5Y price change	-79.57%
5Y return CAGR	-27.21%
5Y total return	-79.57%
6M price change	-38.48%
6M total return	-38.48%
After-hours change	-0.43%
After-hours close	$2.35
After-hours price	$2.34
All-time high	$31.83
All-time high date	2021-02-11
All-time low	$0.90
All-time low date	2022-10-25
Average true range (ATR)	$0.26
Average volume	315.3K
Beta (1Y)	0.65
Beta (2Y)	0.31
Beta (5Y)	0.66
Change from 52-week high	-51.55%
Change from 52-week low	80.77%
Change from all-time high	-92.62%
Change from all-time low	161.11%
Change from open	4.44%
Day's gap	-1.75%
Dollar volume	$252,276
High price	$2.54
Low price	$2.25
Monthly RSI	42.5
Open price	$2.25
Position in 52-week range	35.09%
Previous close	$2.29
Price vs 150-day SMA	-33.3%
Price vs 20-day SMA	-5.85%
Price vs 200-day SMA	-31.45%
Price vs 50-day SMA	-21.3%
Relative volume	0.34
Return from IPO open	-88.48%
Return from IPO price	-87.63%
RSI	40.16
Sharpe ratio	0.71
Sharpe ratio (3Y)	0.62
Sharpe ratio (5Y)	0.03
Sortino ratio	1.23
Sortino ratio (3Y)	1.04
Sortino ratio (5Y)	0.12
Volume	107.4K
Weekly RSI	39.84
YTD price change	24.34%
YTD total return	24.34%

Metric

Value

150-day SMA

$3.52

1D price change

2.62%

1M price change

-17.54%

1M total return

-17.54%

1W price change

-8.91%

1W total return

-8.91%

1Y price change

32.02%

1Y return CAGR

32.05%

1Y total return

32.02%

20-day SMA

$2.50

200-day SMA

$3.43

3M price change

-37.33%

3M total return

-37.33%

3Y price change

73.82%

3Y return CAGR

20.24%

3Y total return

73.84%

50-day SMA

$2.99

50-day SMA vs 200-day SMA

50under200

52-week high

$4.85

52-week high date

2026-07-01

52-week low

$1.30

52-week low date

2025-11-07

5Y price change

-79.57%

5Y return CAGR

-27.21%

5Y total return

-79.57%

6M price change

-38.48%

6M total return

-38.48%

After-hours change

-0.43%

After-hours close

$2.35

After-hours price

$2.34

All-time high

$31.83

All-time high date

2021-02-11

All-time low

$0.90

All-time low date

2022-10-25

Average true range (ATR)

$0.26

Average volume

315.3K

Beta (1Y)

0.65

Beta (2Y)

0.31

Beta (5Y)

0.66

Change from 52-week high

-51.55%

Change from 52-week low

80.77%

Change from all-time high

-92.62%

Change from all-time low

161.11%

Change from open

4.44%

Day's gap

-1.75%

Dollar volume

$252,276

High price

$2.54

Low price

$2.25

Monthly RSI

42.5

Open price

$2.25

Position in 52-week range

35.09%

Previous close

$2.29

Price vs 150-day SMA

-33.3%

Price vs 20-day SMA

-5.85%

Price vs 200-day SMA

-31.45%

Price vs 50-day SMA

-21.3%

Relative volume

0.34

Return from IPO open

-88.48%

Return from IPO price

-87.63%

RSI

40.16

Sharpe ratio

0.71

Sharpe ratio (3Y)

0.62

Sharpe ratio (5Y)

0.03

Sortino ratio

1.23

Sortino ratio (3Y)

1.04

Sortino ratio (5Y)

0.12

Volume

107.4K

Weekly RSI

39.84

YTD price change

24.34%

YTD total return

24.34%

Metric	Value
Float	44.8M
Float percentage	66.76%
Shares change (QoQ)	19.71%
Shares change (YoY)	11.73%
Shares held by insiders	10.11%
Shares held by institutions	43.21%
Shares outstanding	67.1M
Short % of shares	3.7%
Short ratio	5.5 days

Metric

Value

Float

44.8M

Float percentage

66.76%

Shares change (QoQ)

19.71%

Shares change (YoY)

11.73%

Shares held by insiders

10.11%

Shares held by institutions

43.21%

Shares outstanding

67.1M

Short % of shares

3.7%

Short ratio

5.5 days

Adagene Inc. (ADAG)

Price

Financial snapshot

Fair-value bridge

Latest news · ADAG

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ADAG indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ADAG

Frequently asked questions